| DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells Y Saiki, Y Yoshino, H Fujimura, T Manabe, Y Kudo, M Shimada, N Mano, ... Biochemical and biophysical research communications 421 (1), 98-104, 2012 | 123 | 2012 |
| Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells Y Yoshino, C Ishioka Scientific reports 5 (1), 13249, 2015 | 78 | 2015 |
| Regulation of the centrosome cycle H Fujita, Y Yoshino, N Chiba Molecular & cellular oncology 3 (2), e1075643, 2016 | 70 | 2016 |
| S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells H Sekine, N Chen, K Sato, Y Saiki, Y Yoshino, Y Umetsu, G Jin, H Nagase, ... Biochemical and Biophysical Research Communications 429 (3-4), 214-219, 2012 | 41 | 2012 |
| microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer H Takahashi, M Takahashi, S Ohnuma, M Unno, Y Yoshino, K Ouchi, ... BMC cancer 17, 1-14, 2017 | 32 | 2017 |
| RACK1 regulates centriole duplication by controlling localization of BRCA1 to the centrosome in mammary tissue-derived cells Y Yoshino, H Qi, R Kanazawa, M Sugamata, K Suzuki, A Kobayashi, ... Oncogene 38 (16), 3077-3092, 2019 | 27 | 2019 |
| BRCA1-interacting protein OLA1 requires interaction with BARD1 to regulate centrosome number Y Yoshino, H Qi, H Fujita, M Shirota, S Abe, Y Komiyama, K Shindo, ... Molecular Cancer Research 16 (10), 1499-1511, 2018 | 27 | 2018 |
| Evaluation of site-specific homologous recombination activity of BRCA1 by direct quantitation of gene editing efficiency Y Yoshino, S Endo, Z Chen, H Qi, G Watanabe, N Chiba Scientific Reports 9 (1), 1644, 2019 | 23 | 2019 |
| Dysregulation of the centrosome induced by BRCA1 deficiency contributes to tissue‐specific carcinogenesis Y Yoshino, Z Fang, H Qi, A Kobayashi, N Chiba Cancer science 112 (5), 1679-1687, 2021 | 21 | 2021 |
| The function of BARD1 in centrosome regulation in cooperation with BRCA1/OLA1/RACK1 K Otsuka, Y Yoshino, H Qi, N Chiba Genes 11 (8), 842, 2020 | 16 | 2020 |
| A curcumin analog, GO-Y078, effectively inhibits angiogenesis through actin disorganization S Sugiyama, Y Yoshino, S Kuriyama, M Inoue, K Komine, K Otsuka, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016 | 14 | 2016 |
| Roles of RACK1 in centrosome regulation and carcinogenesis Y Yoshino, N Chiba Cellular Signalling 90, 110207, 2022 | 12 | 2022 |
| RACK1 regulates centriole duplication through promoting the activation of polo-like kinase 1 by Aurora A Y Yoshino, A Kobayashi, H Qi, S Endo, Z Fang, K Shindo, R Kanazawa, ... Journal of cell science 133 (17), jcs238931, 2020 | 11 | 2020 |
| Inhibition of invasion by glycogen synthase kinase-3 beta inhibitors through dysregulation of actin re-organisation via down-regulation of WAVE2 Y Yoshino, M Suzuki, H Takahashi, C Ishioka Biochemical and Biophysical Research Communications 464 (1), 275-280, 2015 | 11 | 2015 |
| Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway N Yanaihara, Y Yoshino, D Noguchi, J Tabata, M Takenaka, Y Iida, ... Gynecologic Oncology 168, 83-91, 2023 | 10 | 2023 |
| A new 10-min ligation method using a modified buffer system with a very low amount of T4 DNA ligase: The “Coffee Break Ligation” technique Y Yoshino, M Ishida, A Horii Biotechnology letters 29, 1557-1560, 2007 | 10 | 2007 |
| BRCA1/ATF1-mediated transactivation is involved in resistance to PARP inhibitors and cisplatin S Endo, Y Yoshino, M Shirota, G Watanabe, N Chiba Cancer Research Communications 1 (2), 90-105, 2021 | 8 | 2021 |
| OLA1 gene sequencing in patients with BRCA1/2 mutation-negative suspected hereditary breast and ovarian cancer M Takahashi, N Chiba, H Shimodaira, Y Yoshino, T Mori, M Sumii, ... Breast Cancer 24, 336-340, 2017 | 8 | 2017 |
| Aurora A polyubiquitinates the BRCA1-interacting protein OLA1 to promote centrosome maturation Z Fang, X Li, Y Yoshino, M Suzuki, H Qi, H Murooka, R Katakai, M Shirota, ... Cell Reports 42 (8), 2023 | 6 | 2023 |
| Acute exacerbation of paraneoplastic neurological syndrome after massive tumor lysis of neuroendocrine carcinoma by chemoradiotherapy Y Yoshino, S Akiyama, K Ouchi, T Oishi, H Takahashi, J Lee, S Takahashi, ... International Cancer Conference Journal 2, 247-250, 2013 | 6 | 2013 |
Akira HoriiTohoku University School of Medicine在 med.tohoku.ac.jp 的电子邮件经过验证
